Log in to save to my catalogue

Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococ...

Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococ...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2560833052

Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study

About this item

Full title

Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

European journal of clinical microbiology & infectious diseases, 2021-12, Vol.40 (12), p.2605-2616

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Whether cefazolin is as effective and safer than antistaphylococcal penicillins (ASPs) for the treatment of methicillin-susceptible
Staphylococcus aureus
(MSSA) infective endocarditis (IE) is still debated in the absence of a randomized controlled trial. In this quasi-experimental study, we aimed to assess the effectiveness and safety of thes...

Alternative Titles

Full title

Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2560833052

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2560833052

Other Identifiers

ISSN

0934-9723

E-ISSN

1435-4373

DOI

10.1007/s10096-021-04313-3

How to access this item